{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T19:08:49Z","timestamp":1757617729556,"version":"3.44.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,6]]},"DOI":"10.7759\/cureus.91721","type":"journal-article","created":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T12:18:17Z","timestamp":1757161097000},"source":"Crossref","is-referenced-by-count":0,"title":["Beyond Rejection: Exploring Tacrolimus's Hidden Potential in Toxoplasmosis"],"prefix":"10.7759","author":[{"given":"Benjamin  R","family":"Johnson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna K","family":"Potter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1863-2378.2009.01276.x","article-title":"A brief history and overview of Toxoplasma gondii","volume":"57","author":"Innes EA","year":"2010","unstructured":"Innes EA. A brief history and overview of Toxoplasma gondii. Zoonoses Public Health. 2010, 57:1-7. 10.1111\/j.1863-2378.2009.01276.x","journal-title":"Zoonoses Public Health"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2024.105771","article-title":"Regulation of calcium entry by cyclic GMP signaling in Toxoplasma gondii","volume":"300","author":"Hortua Triana MA","year":"2024","unstructured":"Hortua Triana MA, M\u00e1rquez-Nogueras KM, Fazli MS, Quinn S, Moreno SN. Regulation of calcium entry by cyclic GMP signaling in Toxoplasma gondii. J Biol Chem. 2024, 300:105771. 10.1016\/j.jbc.2024.105771","journal-title":"J Biol Chem"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2020.104549","article-title":"The prevalence of latent and acute toxoplasmosis in HIV-infected pregnant women: a systematic review and meta-analysis","volume":"149","author":"Nourollahpour Shiadeh M","year":"2020","unstructured":"Nourollahpour Shiadeh M, Esfandyari S, Ashrafmansouri M, et al.. The prevalence of latent and acute toxoplasmosis in HIV-infected pregnant women: a systematic review and meta-analysis. Microb Pathog. 2020, 149:104549. 10.1016\/j.micpath.2020.104549","journal-title":"Microb Pathog"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.2000.80.4.1483","article-title":"Calcineurin: form and function","volume":"80","author":"Rusnak F","year":"2000","unstructured":"Rusnak F, Mertz P. Calcineurin: form and function. Physiol Rev. 2000, 80:1483-521. 10.1152\/physrev.2000.80.4.1483","journal-title":"Physiol Rev"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2015.06.003","article-title":"Parasite calcineurin regulates host cell recognition and attachment by apicomplexans","volume":"18","author":"Paul AS","year":"2015","unstructured":"Paul AS, Saha S, Engelberg K, et al.. Parasite calcineurin regulates host cell recognition and attachment by apicomplexans. Cell Host Microbe. 2015, 18:49-60. 10.1016\/j.chom.2015.06.003","journal-title":"Cell Host Microbe"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2174\/1389200219666180129151948","article-title":"Pharmacokinetics, pharmacodynamics and pharmacogenetics of tacrolimus in kidney transplantation","volume":"19","author":"Yu M","year":"2018","unstructured":"Yu M, Liu M, Zhang W, Ming Y. Pharmacokinetics, pharmacodynamics and pharmacogenetics of tacrolimus in kidney transplantation. Curr Drug Metab. 2018, 19:513-22. 10.2174\/1389200219666180129151948","journal-title":"Curr Drug Metab"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1006\/clin.1996.0140","article-title":"The mechanism of action of cyclosporin A and FK506","volume":"80","author":"Ho S","year":"1996","unstructured":"Ho S, Clipstone N, Timmermann L, et al.. The mechanism of action of cyclosporin A and FK506. Clin Immunol Immunopathol. 1996, 80:S40-5. 10.1006\/clin.1996.0140","journal-title":"Clin Immunol Immunopathol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/s0020-7519(00)00124-7","article-title":"Toxoplasma gondii: from animals to humans","volume":"30","author":"Tenter AM","year":"2000","unstructured":"Tenter AM, Heckeroth AR, Weiss LM. Toxoplasma gondii: from animals to humans. Int J Parasitol. 2000, 30:1217-58. 10.1016\/s0020-7519(00)00124-7","journal-title":"Int J Parasitol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens7030069","article-title":"A window to Toxoplasma gondii egress","volume":"7","author":"Caldas LA","year":"2018","unstructured":"Caldas LA, de Souza W. A window to Toxoplasma gondii egress. Pathogens. 2018, 7:69. 10.3390\/pathogens7030069","journal-title":"Pathogens"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00057-17","article-title":"Treatment of toxoplasmosis: historical perspective, animal models, and current clinical practice","volume":"31","author":"Dunay IR","year":"2018","unstructured":"Dunay IR, Gajurel K, Dhakal R, Liesenfeld O, Montoya JG. Treatment of toxoplasmosis: historical perspective, animal models, and current clinical practice. Clin Microbiol Rev. 2018, 31:1-33. 10.1128\/CMR.00057-17","journal-title":"Clin Microbiol Rev"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2008.02091.x","article-title":"Prevention of toxoplasmosis in transplant patients","volume":"14","author":"Derouin F","year":"2008","unstructured":"Derouin F, Pelloux H. Prevention of toxoplasmosis in transplant patients. Clin Microbiol Infect. 2008, 14:1089-101. 10.1111\/j.1469-0691.2008.02091.x","journal-title":"Clin Microbiol Infect"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kev115","article-title":"Toxoplasmosis in immunosuppressed patients","volume":"54","author":"Lewis JM","year":"2015","unstructured":"Lewis JM, Clifford S, Nsutebu E. Toxoplasmosis in immunosuppressed patients. Rheumatology (Oxford). 2015, 54:1939-40. 10.1093\/rheumatology\/kev115","journal-title":"Rheumatology (Oxford)"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.13546","article-title":"Tissue and blood protozoa including toxoplasmosis, Chagas disease, leishmaniasis, Babesia, Acanthamoeba, Balamuthia, and Naegleria in solid organ transplant recipients- Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice","volume":"33","author":"La Hoz RM","year":"2019","unstructured":"La Hoz RM, Morris MI. Tissue and blood protozoa including toxoplasmosis, Chagas disease, leishmaniasis, Babesia, Acanthamoeba, Balamuthia, and Naegleria in solid organ transplant recipients- Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant. 2019, 33:e13546. 10.1111\/ctr.13546","journal-title":"Clin Transplant"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1080\/00325481.2019.1655258","article-title":"Perspective on current and emerging drugs in the treatment of acute and chronic toxoplasmosis","volume":"131","author":"Lapinskas PJ","year":"2019","unstructured":"Lapinskas PJ, Ben-Harari RR. Perspective on current and emerging drugs in the treatment of acute and chronic toxoplasmosis. Postgrad Med. 2019, 131:589-96. 10.1080\/00325481.2019.1655258","journal-title":"Postgrad Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1993.tb17137.x","article-title":"The mechanism of action of FK-506 and cyclosporin A","volume":"696","author":"Wiederrecht G","year":"1993","unstructured":"Wiederrecht G, Lam E, Hung S, Martin M, Sigal N. The mechanism of action of FK-506 and cyclosporin A. Ann N Y Acad Sci. 1993, 696:9-19. 10.1111\/j.1749-6632.1993.tb17137.x","journal-title":"Ann N Y Acad Sci"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s10059-009-0114-z","article-title":"Tacrolimus differentially regulates the proliferation of conventional and regulatory CD4(+) T cells","volume":"28","author":"Kogina K","year":"2009","unstructured":"Kogina K, Shoda H, Yamaguchi Y, Tsuno NH, Takahashi K, Fujio K, Yamamoto K. Tacrolimus differentially regulates the proliferation of conventional and regulatory CD4(+) T cells. Mol Cells. 2009, 28:125-30. 10.1007\/s10059-009-0114-z","journal-title":"Mol Cells"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/imm.12661","article-title":"Tacrolimus prevents murine cerebral malaria","volume":"150","author":"Bao LQ","year":"2017","unstructured":"Bao LQ, Nhi DM, Huy NT, Hamano S, Hirayama K. Tacrolimus prevents murine cerebral malaria. Immunology. 2017, 150:155-61. 10.1111\/imm.12661","journal-title":"Immunology"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.actatropica.2020.105708","article-title":"Tacrolimus, a rapamycin target protein inhibitor, exerts anti-cystic echinococcosis effects both in vitro and in vivo","volume":"212","author":"Muhedier M","year":"2020","unstructured":"Muhedier M, Li J, Liu H, Ma G, Amahong K, Lin R, L\u00fc G. Tacrolimus, a rapamycin target protein inhibitor, exerts anti-cystic echinococcosis effects both in vitro and in vivo. Acta Trop. 2020, 212:105708. 10.1016\/j.actatropica.2020.105708","journal-title":"Acta Trop"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-198605000-00012","article-title":"The effects of cyclosporine on Toxoplasma gondii in vivo and in vitro","volume":"41","author":"McCabe RE","year":"1986","unstructured":"McCabe RE, Luft BJ, Remington JS. The effects of cyclosporine on Toxoplasma gondii in vivo and in vitro. Transplantation. 1986, 41:611-5. 10.1097\/00007890-198605000-00012","journal-title":"Transplantation"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.26.1.26","article-title":"New micromethod to study the effect of antimicrobial agents on Toxoplasma gondii: comparison of sulfadoxine and sulfadiazine individually and in combination with pyrimethamine and study of clindamycin, metronidazole, and cyclosporin A","volume":"26","author":"Mack DG","year":"1984","unstructured":"Mack DG, McLeod R. New micromethod to study the effect of antimicrobial agents on Toxoplasma gondii: comparison of sulfadoxine and sulfadiazine individually and in combination with pyrimethamine and study of clindamycin, metronidazole, and cyclosporin A. Antimicrob Agents Chemother. 1984, 26:26-30. 10.1128\/AAC.26.1.26","journal-title":"Antimicrob Agents Chemother"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1007\/s004360050185","article-title":"Effect of immunosuppressive drug regimens on acute and chronic murine toxoplasmosis","volume":"82","author":"Sumyuen MH","year":"1996","unstructured":"Sumyuen MH, Garin YJ, Derouin F. Effect of immunosuppressive drug regimens on acute and chronic murine toxoplasmosis. Parasitol Res. 1996, 82:681-6. 10.1007\/s004360050185","journal-title":"Parasitol Res"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/524279","article-title":"Fatal Toxoplasma gondii dissemination in a heart transplant recipient: description of a case","volume":"2012","author":"Mastrobuoni S","year":"2012","unstructured":"Mastrobuoni S, Dell'aquila AM, Herreros J. Fatal Toxoplasma gondii dissemination in a heart transplant recipient: description of a case. Case Rep Transplant. 2012, 2012:524279. 10.1155\/2012\/524279","journal-title":"Case Rep Transplant"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.27.3.529-535.1989","article-title":"Indirect enzyme-linked immunosorbent assay for immunoglobulin G and four immunoassays for immunoglobulin M to Toxoplasma gondii in a series of heart transplant recipients","volume":"27","author":"Sluiters JF","year":"1989","unstructured":"Sluiters JF, Balk AH, Essed CE, Mochtar B, Weimar W, Simoons ML, Ijzerman EP. Indirect enzyme-linked immunosorbent assay for immunoglobulin G and four immunoassays for immunoglobulin M to Toxoplasma gondii in a series of heart transplant recipients. J Clin Microbiol. 1989, 27:529-35. 10.1128\/jcm.27.3.529-535.1989","journal-title":"J Clin Microbiol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1111\/tid.13636","article-title":"Clinical characteristics and outcomes of toxoplasmosis among transplant recipients at two US academic medical centers","volume":"23","author":"Adekunle RO","year":"2021","unstructured":"Adekunle RO, Sherman A, Spicer JO, et al.. Clinical characteristics and outcomes of toxoplasmosis among transplant recipients at two US academic medical centers. Transpl Infect Dis. 2021, 23:e13636. 10.1111\/tid.13636","journal-title":"Transpl Infect Dis"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3390\/genes16040391","article-title":"Toxoplasma gondii replication during belatacept treatment in kidney transplantation: a case report and a review of the literature","volume":"16","author":"Vigilante R","year":"2025","unstructured":"Vigilante R, Izhar R, Paola RD, et al.. Toxoplasma gondii replication during belatacept treatment in kidney transplantation: a case report and a review of the literature. Genes (Basel). 2025, 16:391. 10.3390\/genes16040391","journal-title":"Genes (Basel)"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.62.3.9","article-title":"Murine model of primary acquired ocular toxoplasmosis: fluorescein angiography and multiplex immune mediator profiles in the aqueous humor","volume":"62","author":"Li K","year":"2021","unstructured":"Li K, Feng X, Hikosaka K, Norose K. Murine model of primary acquired ocular toxoplasmosis: fluorescein angiography and multiplex immune mediator profiles in the aqueous humor. Invest Ophthalmol Vis Sci. 2021, 62:9. 10.1167\/iovs.62.3.9","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1021\/acsinfecdis.2c00566","article-title":"Structural basis for cyclosporin isoform-specific inhibition of cyclophilins from Toxoplasma gondii","volume":"9","author":"Favretto F","year":"2023","unstructured":"Favretto F, Jim\u00e9nez-Faraco E, Conter C, Dominici P, Hermoso JA, Astegno A. Structural basis for cyclosporin isoform-specific inhibition of cyclophilins from Toxoplasma gondii. ACS Infect Dis. 2023, 9:365-77. 10.1021\/acsinfecdis.2c00566","journal-title":"ACS Infect Dis"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-024-01398-5","article-title":"Tacrolimus-induced neurotoxicity after transplant: a literature review","volume":"47","author":"Verona P","year":"2024","unstructured":"Verona P, Edwards J, Hubert K, et al.. Tacrolimus-induced neurotoxicity after transplant: a literature review. Drug Saf. 2024, 47:419-38. 10.1007\/s40264-024-01398-5","journal-title":"Drug Saf"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1038\/kisup.2011.14","article-title":"Pharmacogenetics of tacrolimus: ready for clinical translation?","volume":"1","author":"Coto E","year":"2011","unstructured":"Coto E, Tavira B, Su\u00e1rez-\u00c1lvarez B, L\u00f3pez-Larrea C, D\u00edaz-Corte C, Ortega F, Alvarez V. Pharmacogenetics of tacrolimus: ready for clinical translation?. Kidney Int Suppl (2011). 2011, 1:58-62. 10.1038\/kisup.2011.14","journal-title":"Kidney Int Suppl (2011)"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200225100-00003","article-title":"Drug interactions with tacrolimus","volume":"25","author":"van Gelder T","year":"2002","unstructured":"van Gelder T. Drug interactions with tacrolimus. Drug Saf. 2002, 25:707-12. 10.2165\/00002018-200225100-00003","journal-title":"Drug Saf"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.parepi.2025.e00421","article-title":"Seroprevalence and risk factors for Toxoplasma gondii infection in solid organ transplant patients: a global systematic review and meta-analysis","volume":"29","author":"Mamizadeh M","year":"2025","unstructured":"Mamizadeh M, Maleki F, Mohammadi MR, Shamsi L, Asghari A, Pouryousef A. Seroprevalence and risk factors for Toxoplasma gondii infection in solid organ transplant patients: a global systematic review and meta-analysis. Parasite Epidemiol Control. 2025, 29:e00421. 10.1016\/j.parepi.2025.e00421","journal-title":"Parasite Epidemiol Control"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28730-w","article-title":"In vitro maturation of Toxoplasma gondii bradyzoites in human myotubes and their metabolomic characterization","volume":"13","author":"Christiansen C","year":"2022","unstructured":"Christiansen C, Maus D, Hoppenz E, et al.. In vitro maturation of Toxoplasma gondii bradyzoites in human myotubes and their metabolomic characterization. Nat Commun. 2022, 13:1168. 10.1038\/s41467-022-28730-w","journal-title":"Nat Commun"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/385125-beyond-rejection-exploring-tacrolimuss-hidden-potential-in-toxoplasmosis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T12:18:17Z","timestamp":1757161097000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/385125-beyond-rejection-exploring-tacrolimuss-hidden-potential-in-toxoplasmosis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,6]]},"references-count":32,"URL":"https:\/\/doi.org\/10.7759\/cureus.91721","relation":{},"ISSN":["2168-8184"],"issn-type":[{"type":"print","value":"2168-8184"}],"subject":[],"published":{"date-parts":[[2025,9,6]]}}}